(MedPage Today) -- At the recent Maui Derm, George Martin, MD, founder and program director of the meeting, shared major developments in therapeutics for psoriatic disease -- particularly in the...

(MedPage Today) -- The FDA cleared a prescription smartphone app, dubbed LumosityRx, to help improve attention in adults with attention deficit-hyperactivity disorder (ADHD), maker Lumos Labs announced. Teva Pharmaceutical submitted...

(MedPage Today) -- The number of concierge and direct primary care practices in the U.S. rose sharply in recent years, as did the number of clinicians providing such care, researchers...

1 in 5 patients living with HIV on antiretroviral therapy reported experiencing undesired weight gain in the past 1 year, a new study finds. Medscape Medical News Source link :...

(MedPage Today) -- At the recent American Society of Hematology annual meeting, researchers presented data highlighting new behavioral and family-centered strategies to improve adherence to oral chemotherapy in pediatric acute...

A noninvasive AI tool may be able to predict potential cardiovascular events in patients with suspected stable coronary artery disease, according findings from the FISH&CHIPS study presented at the EACVI...

(MedPage Today) -- A fully remote tailored weight-loss program showed potential for helping veterans with obesity and serious mental illness lose weight, a randomized trial showed. Among 256 veterans, weight...

(MedPage Today) -- Dana-Farber Cancer Institute will pay $15 million to resolve allegations it violated the False Claims Act by making materially false statements and certifications related to NIH research...

(MedPage Today) -- The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter...

An artist’s impression of PSR J2322-2650bNASA, ESA, CSA, Ralf Crawford (STScI) Astronomers have found what appears to be one of the strangest known worlds in the universe. It orbits a...

(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. FDA Travel Spending During Shutdown Draws Scrutiny The...

In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with prurigo nodularis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/first-class-monoclonal-antibody-safe-effective-patients-2025a1000zg6?src=rss Author : Publish date : 2025-12-17...

Chronic fatigue syndrome doesn’t have a single cause, but the role of genetics is starting to come to lightanusorn nakdee/Getty Images We’re starting to get a handle on the role...

(MedPage Today) -- A former leading scientist at the National Institutes of Health (NIH) sued the Trump administration Tuesday, saying she was illegally fired for warning that abrupt research cuts...

(MedPage Today) -- A doctor who pleaded guilty in a scheme to supply ketamine to actor Matthew Perry before his overdose death was sentenced Tuesday to 8 months of home...

Getty ImagesRuth CleggHealth and wellbeing reporter More babies are being born by caesarean section in England than delivered naturally - without assistance - for the first time.Latest NHS data for...

(MedPage Today) -- Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comes with a heavy quality-of-life burden that doesn't disappear after the early disease phase. This rare but heterogeneous disease causes systemic...

(MedPage Today) -- The CDC has formally adopted a recommendation from its vaccine advisory panel to stop recommending hepatitis B vaccination for every newborn at birth. The agency said Tuesday...

(MedPage Today) -- Note that some links may require registration or subscription. Harvey Risch, MD, PhD, a Yale emeritus professor who was appointed chairman of the President's Cancer Panel, has...

(MedPage Today) -- The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The subcutaneous...